Finding into death of James Stewart Dougan
Deceased
James Stewart Dougan
Demographics
32y, male
Date of death
2010-11-19
Finding date
2015-07-24
Cause of death
Mixed drug toxicity (codeine, methadone, alprazolam, diazepam) in a man with coronary artery atherosclerosis
AI-generated summary
James Dougan, 32-year-old man with longstanding polysubstance abuse, died from mixed drug toxicity (codeine, methadone, alprazolam, diazepam) complicated by severe coronary artery atherosclerosis. He engaged in prescription shopping across nine different doctors within 12 months, obtaining 900 tablets of alprazolam alone in five months prior to death. Critical clinical failures included: multiple GPs prescribing benzodiazepines concurrently without coordination; continued prescribing despite documented drug-seeking behaviour; inadequate application of existing guidelines; and reliance on a Prescription Shopping Program with thresholds too high to detect his activity. Real-time prescription monitoring was unavailable. The coroner identified systemic failures in benzodiazepine prescribing practices, monitoring systems, and inter-practitioner communication that contributed to his preventable death.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Error types
Contributing factors
- Prescription shopping across multiple GPs
- Concurrent prescribing of benzodiazepines by multiple practitioners
- Inadequate monitoring of drug-seeking behaviour
- Prescription Shopping Program threshold too high to detect activity
- No real-time prescription monitoring system in Victoria
- Lack of communication between prescribing doctors
- Private script prescribing not captured in PBS records
- Absence of methadone treatment permit
- Severe coronary artery atherosclerosis (90% stenosis LAD)
- Polysubstance abuse with central nervous system depressants
Coroner's recommendations
- Victorian Department of Health progress implementation of Victorian-based real-time prescription monitoring system as matter of urgency to prevent harms and deaths from pharmaceutical drug misuse
- Victorian Department of Health identify legislative and regulatory barriers preventing Schedule 4 drugs (particularly benzodiazepines) being monitored in real-time prescription monitoring program and consider necessary reforms for future expansion beyond Schedule 8 drugs
- Australian Government Department of Human Services review how Medicare Australia responds to Prescription Shopping Information Service queries to ensure medical practitioners understand limitations of the Service and that many drug seekers do not meet the Prescription Shopping Program threshold
- Australian Government Department of Human Services introduce practice whereby when medical practitioner contacts Medicare Australia Prescription Shopping Information Service regarding Victorian patient, practitioner is informed that if concerns exist about patient being drug seeker regardless of Prescription Shopping Program status, notification should be made to Drugs and Poisons Regulation at Victorian Department of Health as required under Drugs Poisons and Controlled Substances Act 2006 (Vic)
Full text
Related cases
Source and disclaimer
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —